IRIS
BELLOTTI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.105
AS - Asia 6.140
EU - Europa 4.892
SA - Sud America 764
AF - Africa 159
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.941
CN - Cina 3.067
SG - Singapore 1.322
IE - Irlanda 1.113
HK - Hong Kong 685
UA - Ucraina 616
BR - Brasile 582
FI - Finlandia 556
RU - Federazione Russa 508
DE - Germania 497
VN - Vietnam 459
IT - Italia 438
FR - Francia 331
GB - Regno Unito 291
SE - Svezia 271
IN - India 151
BD - Bangladesh 90
CA - Canada 84
ZA - Sudafrica 68
AR - Argentina 62
PL - Polonia 55
MX - Messico 53
TR - Turchia 48
JP - Giappone 44
BE - Belgio 39
IQ - Iraq 38
NL - Olanda 33
ES - Italia 30
ID - Indonesia 30
CO - Colombia 26
VE - Venezuela 26
PK - Pakistan 25
EC - Ecuador 22
MA - Marocco 22
TN - Tunisia 18
UZ - Uzbekistan 18
PH - Filippine 17
SA - Arabia Saudita 17
KE - Kenya 16
CZ - Repubblica Ceca 15
AT - Austria 12
CL - Cile 12
IL - Israele 12
JO - Giordania 12
BO - Bolivia 11
IR - Iran 10
KR - Corea 10
LT - Lituania 10
PE - Perù 10
PY - Paraguay 10
DK - Danimarca 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
EG - Egitto 8
HR - Croazia 8
HU - Ungheria 7
JM - Giamaica 7
KG - Kirghizistan 7
LV - Lettonia 7
MU - Mauritius 7
MY - Malesia 7
AZ - Azerbaigian 6
NZ - Nuova Zelanda 6
OM - Oman 6
RO - Romania 6
AL - Albania 5
CH - Svizzera 5
GR - Grecia 5
PT - Portogallo 5
SN - Senegal 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KW - Kuwait 4
LB - Libano 4
MD - Moldavia 4
NI - Nicaragua 4
NP - Nepal 4
RS - Serbia 4
BG - Bulgaria 3
CR - Costa Rica 3
EE - Estonia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
MN - Mongolia 2
SV - El Salvador 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
Totale 20.053
Salva come PNG Salva come JPEG
Città #
Dublin 1.111
Chandler 1.034
San Jose 923
Jacksonville 752
Singapore 677
Hong Kong 666
Nanjing 665
Ashburn 663
Dallas 578
Beijing 539
Boardman 330
Nanchang 277
Princeton 222
Shenyang 202
Wilmington 200
Hebei 185
Lauterbourg 185
Lawrence 184
Ann Arbor 176
Los Angeles 175
Changsha 174
Helsinki 160
Medford 154
Ho Chi Minh City 146
Jiaxing 135
New York 123
Hanoi 110
Tianjin 106
Munich 104
Buffalo 97
Hangzhou 95
Milan 93
Moscow 89
Council Bluffs 88
Shanghai 76
Woodbridge 75
Redondo Beach 71
São Paulo 61
Johannesburg 56
Orem 54
Turku 51
Pavia 46
Santa Clara 46
The Dalles 42
Verona 42
Falls Church 40
Brussels 38
Tokyo 38
Warsaw 38
Chennai 34
Chicago 34
Denver 31
Frankfurt am Main 31
Toronto 31
Norwalk 30
Piscataway 30
Brooklyn 29
Montreal 28
Fairfield 26
London 26
Seattle 24
Da Nang 23
Stockholm 23
Houston 22
Phoenix 22
Haiphong 20
Mexico City 20
Rio de Janeiro 20
San Francisco 20
Ankara 19
Guangzhou 19
Jinan 19
Atlanta 18
Belo Horizonte 18
Falkenstein 18
Boston 17
Baghdad 16
Mumbai 16
Rome 16
Amsterdam 15
Auburn Hills 15
Tashkent 15
Washington 15
Charlotte 13
Manchester 13
Nuremberg 13
Biên Hòa 12
Curitiba 12
Istanbul 12
Kunming 12
Nairobi 12
Ningbo 12
Poplar 12
Caracas 11
Lahore 11
Porto Alegre 11
Zhengzhou 11
Buenos Aires 10
Can Tho 10
Hải Dương 10
Totale 13.149
Salva come PNG Salva come JPEG
Nome #
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 210
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 200
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 179
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 171
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis 159
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 156
Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. 149
Biological activity and pathological implications of misfolded proteins. 148
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 148
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. 142
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 140
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy 140
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 139
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 139
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 139
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 139
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 136
WALDENSTROM'S HYPERGLOBULINEMIC PURPURA IN HLA IDENTICAL SISTERS. 133
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 133
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 131
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 130
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 130
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 129
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 129
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 127
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 127
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 127
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 126
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 126
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 124
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 124
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 123
Capillary electrophoresis investigation of a partially unfolded conformation of Beta 2-microglobulin. 123
AMYLOIDOSIS AL 121
“Separation and quantification of two beta2-microglobulin isoforms”. 121
beta 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation 121
Biochimica Applicata 121
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 119
C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis 119
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 118
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 118
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 118
Amyloid persistence in decellularized liver: Biochemical and histopathological characterization 118
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 117
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers. 117
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 117
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid 117
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 116
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 116
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 116
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 116
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 115
Cerebrospinal fluid ferritin in human disease. 113
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 112
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 112
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 112
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 112
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 111
Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component 110
CHRONIC LYMPHOCYTIC LEUKAEMIA OR IDIOPATHIC COLD HAEMAGGLUTININ DISEASE? A DILEMMA RAISED BY AN ERRONEOUS ELECTRONIC CELL COUNT 107
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 107
Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implication 106
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 106
USE OF A MONOCLONAL ANTIBODY AGAINST HUMAN HEART FERRITIN FOR EVALUATING ACIDIC FERRITIN CONCENTRATION IN HUMAN SERUM 105
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 105
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 104
A Narrative Review of the Role of Transthyretin in Health and Disease 104
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. 103
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. 103
Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- And Long-Distance Conformational Changes 103
DETECTION OF FRAGMENTS OF BETA2-MICROGLOBULIN IN AMYLOID FIBRILS 103
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 102
Proteomics of beta2-microglobulin amyloid fibrils. 102
Cinetiche di refolding e studi di affinità mediante elettroforesi capillare: effetto di ligandi di interesse farmaceutico sulla conformazione della Beta 2-microglobulina 102
Development of a method to screen potential ligands of amyloidogenic proteins 102
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 102
Conformational transition and cellular toxicity by amyloidogenic proteins 101
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin 101
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. 101
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils 100
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile 99
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 98
Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability 98
Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity 98
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 98
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine 98
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 97
Targeting C-reactive protein for the treatment of cardiovascular disease. 97
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 96
Nanobodies against beta2-microglobulin. 96
Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro 96
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 95
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 95
Solution structure of beta(2)-microglobulin and insights into fibrillogenesis 94
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes. 94
An Asp to Asn mutation is a toxic trigger in beta-2 microglobulin: structure and biophysics 94
A CASE OF IgM(KAPPA) MONOCLONAL GAMMOPATHY SIMULATING AN IgM-IgG BICLONAL GAMMOPATHY. 94
Structural and folding dynamics properties of T70N variant of human lysozyme. 94
Misidentification of transthyretin and immunoglobulin variants by proteomics due to methyl lysine formation in formalin-fixed paraffin-embedded amyloid tissue 93
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly. 92
Totale 11.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022905 15 7 11 13 28 56 18 64 58 36 132 467
2022/20233.045 365 239 26 219 315 280 0 160 1.307 20 64 50
2023/2024968 136 202 40 57 104 222 12 48 8 41 69 29
2024/20252.973 71 240 78 94 76 111 113 222 779 91 336 762
2025/20267.075 536 499 823 782 842 326 1.394 245 602 573 205 248
Totale 20.340